RIFAMPIN - CLINICAL STUDIES WITH A NEW ANTIBIOTIC

被引：13

作者：

BRICKNER, PW

机构：

[1] Department of Medicine, Section of Clinical Pharmacology, St. Vincent's Hospital and Medical Center of New York, New York

来源：

JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS | 1969年 / 9卷 / 04期

关键词：

D O I：

10.1177/009127006900900407

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：243 / &

共 20 条

[1]

ARIOLI V, 1967, ARZNEI-FORSCHUNG, V17, P523

[2] LABORATORY AND CLINICAL EVALUATION OF RIFAMPICIN [J].

ATLAS, E ;

TURCK, M .

[3]

BAUER AW, 1960, ANTIBIOTICS ANNUAL 1, P574

[4]

Clark J, 1967, Tubercle, V48, P144, DOI 10.1016/S0041-3879(67)80009-6

[5]

COHN HD, 1969, J CLIN PHARMACOL N D, V9, P118

[6]

DADDI G., 1967, WIEN MED WOCHENSCHR, V117, P266

[7]

FURESZ S, 1967, ARZNEI-FORSCHUNG, V17, P534

[8]

HAEGI V, 1967, SCHWEIZ MED WSCHR, V97, P1011

[9] SPECIFIC INHIBITION OF DNA-DIRECTED RNA SYNTHESIS BY RIFAMYCIN [J].

HARTMANN, G ;

HONIKEL, KO ;

KNUSEL, F ;

NUESCH, J .

[10]

HOBBY GL, 1968, AM REV RESPIR DIS, V97, P713